AUS Edition 
NZ Edition 
UK Edition 
CA Edition 
USA Edition 
FRA Edition 
GER Edition 
ESP Edition 
ITA Edition 
NLD Edition 
PRT Edition 
SWE Edition 
GRC Edition 
IND Edition 
POL Edition 
BRA Edition 
ZAF Edition 
RUS Edition 
CHN Edition 
UAE Edition 
⚠
✓
RadNet Inc (NASDAQ:RDNT)
56.2 USD
+0.550 0.988%Sponsored Reports
Loading...
| Previous Close (in USD) | 55.65 |
|---|---|
| Change | +0.550 0.988% |
| 52 W H/L (in USD) | 93.650/45.001 |
| EBITDA (in USD) | 224.191M |
| PE Ratio | -- |
| Volume | 251969 |
| Diluted Eps TTM | -0.43 |
| Total Assets (in USD) | 3286.69M |
|---|---|
| Total Liabilities (in USD) | 2153.28M |
| Revenue TTM (in USD) | 1869.356M |
| Cash (in USD) | 740.02M |
| Market Cap (in USD) | 4,587.340 M |
| Revenue Per Share TTM | 25.158 |
| Gross Profit TTM (in USD) | 347.802M |
Summary
Income Statement
Balance Sheet
Change in Cash
Operating Cash
Dividend Paid
RadNet Inc
RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as solutions for prostate cancer screening. In addition, it develops and delivers AI-powered health informatics solutions to drive quality, efficiency, and outcomes in imaging and radiology; informatics designed for outpatient radiology; and DeepHealth OS, a cloud-native operating system that helps in the operations of the radiology service. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.
Employees: 11000
Key Executives
| Sr. No. | Name | Title | Year Born |
|---|---|---|---|
| 1. | Dr. Howard G. Berger M.D. | Chairman, Pres & CEO | 1946 |
| 2. | Mr. Mark D. Stolper | Exec. VP & CFO | 1971 |
| 3. | Mr. Mital Patel | Exec. VP of Financial Planning & Analysis and Chief Admin. Officer | 1986 |
| 4. | Mr. Norman R. Hames | Pres & COO of Western Operations | 1956 |
| 5. | Mr. Stephen M. Forthuber | Pres & COO of Eastern Operations | 1961 |
| 6. | Ms. Christine Nayoma Gordon | Sr. VP of Operations - Northern California & Director | 1963 |
| 7. | Ms. Ruth Louisa Villiger-Wilson | HR Advisor & Director | 1964 |
| 8. | Mr. Ranjan Jayanathan | Exec. VP, Chief Information Officer & GM of eRAD - Radiology Information Technology Division | 1956 |
| 9. | Ms. Laura Foster BSRT, MPH, J.D. | Sr. VP of Compliance & Regulatory Affairs | NA |
| 10. | Mr. David Jeffrey Katz | Exec. VP, Gen. Counsel & Corp. Sec. | 1964 |
Peers
Sector: Healthcare
Industry: Diagnostics & Research
| Company | Change (USD) | Price (USD) | Trailing PE(x) | Forward PE(x) | Price Sales TTM(x) | Price to Book Value(x) | Enterprise Value to Revenue(x) | Enterprise Value to EBITDA(x) |
|
TMO
Thermo Fisher Scientific Inc |
+1.570 0.367% | 428.62 | 34.710 | 23.866 | 4.622 | 4.428 | 5.293 | 20.886 |
|
DHR
Danaher Corporation |
+0.700 0.346% | 203.3 | 29.090 | 28.011 | 5.669 | 3.198 | 5.999 | 19.094 |
|
A
Agilent Technologies Inc |
+0.720 0.597% | 121 | 34.360 | 26.385 | 6.587 | 7.136 | 6.781 | 23.557 |
|
IDXX
IDEXX Laboratories Inc |
+4.300 0.792% | 539.02 | 49.990 | 45.662 | 11.293 | 27.850 | 11.461 | 34.457 |
Income Statement
(Currency in USD)| Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
|---|---|---|---|---|---|
| Income Before Tax | 42.969M | 58.879M | -0.854M | 29.669M | 38.527M |
| Minority Interest | 22.958M | 19.592M | 92.56M | 8.684M | 5.89M |
| Net Income | 33.608M | 44.319M | -1.749M | 23.44M | 32.243M |
| Selling General Administrative | 1265.292M | 1124.018M | 970.255M | 1001.311M | 869.478M |
| Gross Profit | 165.715M | 191.803M | 105.938M | 154.487M | 107.599M |
| Reconciled Depreciation | 184.724M | 170.661M | 154.71M | 147.449M | 72.899M |
| Ebit | 46.363M | 82.554M | 53.232M | 69.878M | 85.797M |
| Ebitda | 243.119M | 264.734M | 207.942M | 229.164M | 158.696M |
| Depreciation And Amortization | 196.756M | 182.18M | 154.71M | 159.286M | 72.899M |
| Operating Income | 46.363M | 82.554M | 53.232M | 69.878M | 30.886M |
| Other Operating Expenses | 1380.223M | 1210.858M | 1026.433M | 1080.299M | 940.446M |
| Interest Expense | 50.841M | 48.83M | 45.882M | 48.044M | 43.456M |
| Tax Provision | 9.361M | 14.56M | 0.895M | 6.229M | 0.394M |
| Interest Income | - | - | - | 39.694M | 39.539M |
| Net Interest Income | -50.841M | -48.83M | -45.882M | -48.044M | -43.456M |
| Income Tax Expense | 9.361M | 14.56M | 0.895M | 6.229M | 0.394M |
| Total Revenue | 1430.061M | 1315.077M | 1071.84M | 1154.179M | 975.146M |
| Total Operating Expenses | 115.877M | 87.584M | 60.531M | 80.607M | 72.899M |
| Cost Of Revenue | 1264.346M | 1123.274M | 965.902M | 999.692M | 867.547M |
| Total Other Income Expense Net | -3.394M | -23.675M | -54.086M | -40.209M | 47.283M |
| Net Income From Continuing Ops | 33.608M | 44.319M | -1.749M | 23.44M | 38.133M |
| Net Income Applicable To Common Shares | 10.65M | 24.727M | -14.84M | 14.756M | 32.243M |
Balance Sheet
(Currency in USD)| Breakdown | 31-12-2024 | 31-12-2023 | 31-12-2022 | 31-12-2021 | 31-12-2020 |
|---|---|---|---|---|---|
| Total Assets | 3286.69M | 2886.693M | 2433.907M | 2058.474M | 1786.657M |
| Intangible Assets | 81.351M | 90.615M | 106.228M | 56.603M | 52.393M |
| Other Current Assets | 51.542M | 47.657M | 54.022M | 49.212M | 32.985M |
| Total Liab | 2153.28M | 2073.334M | 1942.455M | 1712.317M | 1528.354M |
| Total Stockholder Equity | 902.308M | 630.695M | 332.995M | 228.904M | 165.743M |
| Other Current Liab | 298.664M | 235.962M | 23.1M | 23.53M | 14.01M |
| Common Stock | 0.007M | 0.007M | 0.006M | 0.005M | 0.005M |
| Capital Stock | 0.007M | 0.007M | 0.006M | 0.005M | 0.005M |
| Retained Earnings | -76.785M | -79.578M | -82.622M | -93.272M | -117.999M |
| Good Will | 710.663M | 679.463M | 677.665M | 513.82M | 472.879M |
| Other Assets | - | - | 55.452M | 53.02M | 73.437M |
| Cash | 740.02M | 342.57M | 127.834M | 134.606M | 102.018M |
| Cash And Equivalents | - | - | - | - | - |
| Total Current Liabilities | 479.712M | 437.452M | 466.723M | 374.784M | 398.114M |
| Current Deferred Revenue | 3.288M | 4.647M | 4.021M | 10.701M | 39.257M |
| Net Debt | 988.843M | 1148.55M | 1385.634M | 1263.183M | 1082.897M |
| Short Term Debt | 81.31M | 73.955M | 70.007M | 76.616M | 108.163M |
| Short Long Term Debt | 24.692M | 17.974M | 12.4M | 11.164M | 39.791M |
| Short Long Term Debt Total | 1728.863M | 1491.12M | 1513.468M | 1397.789M | 1184.915M |
| Other Stockholder Equity | 988.147M | 722.75M | 436.288M | 342.592M | 307.788M |
| Property Plant Equipment | - | - | 565.961M | 1068.538M | 882.996M |
| Total Current Assets | 1019.252M | 579.276M | 367.184M | 324.264M | 270.424M |
| Long Term Investments | 104.057M | 92.71M | 57.893M | 42.229M | 34.528M |
| Short Term Investments | - | - | - | - | 34.528M |
| Net Receivables | 227.69M | 189.049M | 185.328M | 140.446M | 135.421M |
| Long Term Debt | 991.574M | 812.068M | 839.344M | 743.498M | 612.913M |
| Inventory | - | 0M | - | - | - |
| Accounts Payable | 96.45M | 122.888M | 369.595M | 263.937M | 236.684M |
| Accumulated Other Comprehensive Income | -9.061M | -12.484M | -20.677M | -20.421M | -24.051M |
| Non Currrent Assets Other | 36.836M | 47.976M | 55.452M | 38.167M | 38.75M |
| Non Current Assets Total | 2267.438M | 2307.417M | 2066.723M | 1734.21M | 1516.233M |
| Capital Lease Obligations | 712.597M | 661.078M | 661.724M | 643.127M | 532.211M |
| Long Term Debt Total | - | - | 839.344M | 743.498M | 612.913M |
Cash Flow
(Currency in USD)| Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
|---|---|---|---|---|---|
| Investments | -1.441M | -1.441M | -126.244M | 0.678M | -4.2M |
| Total Cashflows From Investing Activities | -246.949M | -221.511M | -126.244M | -99.465M | -146.749M |
| Total Cash From Financing Activities | 93.647M | 104.673M | -45.561M | 24.951M | -10.869M |
| Net Income | 33.608M | 44.319M | -1.749M | 23.44M | 38.133M |
| Change In Cash | -6.772M | 32.588M | 61.853M | 29.776M | -40.933M |
| Begin Period Cash Flow | 134.606M | 102.018M | 40.165M | 10.389M | 51.322M |
| End Period Cash Flow | 127.834M | 134.606M | 102.018M | 40.165M | 10.389M |
| Total Cash From Operating Activities | 146.417M | 149.491M | 233.759M | 104.322M | 116.754M |
| Depreciation | 184.724M | 170.661M | 154.71M | 147.449M | 72.899M |
| Other Cashflows From Investing Activities | -126.057M | -82.196M | -30.437M | 1.16M | 2.823M |
| Dividends Paid | - | 6.26M | 1.577M | - | 1.427M |
| Change To Inventory | - | -87.668M | -45.069M | -17.316M | -10.935M |
| Sale Purchase Of Stock | -0.599M | -1.938M | -1.985M | -2.982M | -1.607M |
| Other Cashflows From Financing Activities | 147.103M | 855.804M | 252.197M | 361.387M | 205.333M |
| Capital Expenditures | 249.412M | 220.695M | 125.437M | 101.303M | 145.372M |
| Change In Working Capital | -58.696M | -92.128M | 54.862M | -77.85M | 18.349M |
| Other Non Cash Items | -50.345M | 22.929M | 4.655M | 0.69M | -13.354M |
| Free Cash Flow | -102.995M | -71.204M | 108.322M | 3.019M | -28.618M |
Funds
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | iShares Core S&P Small-Cap ETF | 2 months ago | 3978934 |
| 2. | Vanguard Total Stock Mkt Idx Inv | 3 months ago | 2098287 |
| 3. | Vanguard Small Cap Index | 2 months ago | 1672581 |
| 4. | iShares Russell 2000 ETF | 2 months ago | 1634322 |
| 5. | UBS: US Equity Small Cap Growth | 9 months ago | 999158 |
| 6. | Vanguard Institutional Extnd Mkt Idx Tr | 3 months ago | 996962 |
| 7. | Vanguard Small Cap Growth Index Inv | 2 months ago | 931280 |
| 8. | American Century Small Cap Growth Inv | 3 months ago | 838102 |
| 9. | American Century U.S. Small Cap Growth | 3 months ago | 838102 |
| 10. | Invesco OFI Small Cap Growth | 3 months ago | 825012 |
| 11. | Invesco Discovery A | 3 months ago | 825012 |
| 12. | Hood River Small-Cap Growth Instl | 6 months ago | 754651 |
| 13. | T. Rowe Price Small-Cap Stock | 3 months ago | 698891 |
| 14. | T. Rowe Price US Small-Cap Core Equity | 3 months ago | 698891 |
| 15. | Fidelity Small Cap Index | 4 months ago | 655299 |
| 16. | Baron Opp. Small Cap Growth Strategy | 3 months ago | 650000 |
| 17. | Baron Small Cap Retail | 3 months ago | 650000 |
| 18. | iShares Russell 2000 Growth ETF | 2 months ago | 587699 |
| 19. | iShares S&P Small-Cap 600 Growth ETF | 2 months ago | 581836 |
| 20. | SPDR® Portfolio S&P 600™ Sm Cap ETF | 2 months ago | 562668 |
Institutions
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | BlackRock Inc | 3 months ago | 9985471 |
| 2. | Vanguard Group Inc | 3 months ago | 7299327 |
| 3. | Beck, Mack & Oliver LLC | 3 months ago | 3280449 |
| 4. | State Street Corp | 3 months ago | 2479532 |
| 5. | RTW INVESTMENTS, LLC | 3 months ago | 2317582 |
| 6. | Amvescap Plc. | 6 months ago | 1731074 |
| 7. | Allspring Global Investments Holdings, LLC | 3 months ago | 1689275 |
| 8. | Geode Capital Management, LLC | 6 months ago | 1553629 |
| 9. | Jb Capital Partners LP | 6 months ago | 1474061 |
| 10. | Dimensional Fund Advisors, Inc. | 3 months ago | 1402899 |
| 11. | Hood River Capital Management LLC | 3 months ago | 1356115 |
| 12. | Principal Financial Group Inc | 3 months ago | 1330577 |
| 13. | American Century Companies Inc | 3 months ago | 1272928 |
| 14. | Marshall Wace Asset Management Ltd | 6 months ago | 1222690 |
| 15. | Alyeska Investment Group, L.P. | 3 months ago | 1214882 |
| 16. | ClearBridge Advisors, LLC | 6 months ago | 942082 |
| 17. | T. Rowe Price Investment Management,Inc. | 6 months ago | 913691 |
| 18. | Loomis, Sayles & Company LP | 3 months ago | 817554 |
| 19. | NORGES BANK | 6 months ago | 807289 |
| 20. | Northern Trust Corp | 6 months ago | 772088 |
Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).
Sponsored Articles
Loading...
Related Articles
Loading...